NHC
National HealthCare Corporation · Healthcare · Medical - Care Facilities
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 84 | +5 | 7.12M | $1.51B | +9 | −4 |
| Q1 2026 | 82 | -2 | 6.91M | $1.10B | +4 | −6 |
| Q4 2025 | 84 | 0 | 7.44M | $1.02B | +1 | −1 |
| Q3 2025 | 14 | -2 | 4.85M | $590.24M | — | −2 |
| Q2 2025 | 13 | +1 | 4.66M | $498.80M | +1 | — |
| Q1 2025 | 9 | +2 | 1.32M | $122.67M | +2 | — |
| Q4 2024 | 7 | -4 | 1.24M | $133.72M | — | −4 |
| Q3 2024 | 10 | +1 | 803.83K | $101.11M | +1 | — |
| Q2 2024 | 9 | — | 813.70K | $88.21M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 398.17K | — | $43.16M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 302.20K | — | $32.76M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 302.20K | — | $32.76M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Arrowstreet Capital ✦ | 59.32K | — | $6.43M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 27.80K | — | $3.01M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 27.80K | — | $3.01M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Bridgewater Associates ✦ | 10.38K | — | $1.12M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 5.88K | — | $637,000 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 5.82K | — | $630,346 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 2.10K | — | $227,640 | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 2.05K | — | $222,112 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 236 holders, 10.21M shares, $1.54B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 1.50K sh · $355,620
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology